# Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity

> **NCT05442177** · — · COMPLETED · sponsor: **Taichung Tzu Chi Hospital** · enrollment: 35 (actual)

## Conditions studied

- Myelosuppression

## Interventions

- **PROCEDURE:** Chemotherapy and Integrated Chinese Medicine With Western Medicine for cancer treatment

## Key facts

- **NCT ID:** NCT05442177
- **Lead sponsor:** Taichung Tzu Chi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-01
- **Primary completion:** 2016-06-30
- **Final completion:** 2016-06-30
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05442177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05442177, "Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05442177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*